Alternatives to ALP Bio
ALP Bio is a Biotechnology tool: combines human immune organoid biology with generative AI to reduce immunogenicity risk in antibody development. Here are the 51 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to ALP Bio
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Spark TherapeuticsNot ratedA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
Janux TherapeuticsNot ratedA clinical-stage biopharmaceutical company developing novel immunotherapies.
KaliVir Immunotherapeutics, Inc.5.0 out of 5 (1)Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
- EAEarendil LabsNot rated
Earendil Labs is an AI biotechnology company focused on leveraging artificial intelligence for drug discovery and development of next-generation biologics.
Anagram TherapeuticsNot ratedClinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.
Verdiva Bio3.0 out of 5 (1)Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
Gossamer BioNot ratedA biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.
CellaresNot ratedThe first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.
Celea TherapeuticsNot ratedAdvancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).
Ray TherapeuticsNot ratedPioneering vision restoration therapies for severe retinal degenerations.
ParcelBioNot ratedAdvancing next-generation mRNA medicines.
Immix Biopharma, Inc.Not ratedA clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.
Tortugas NeuroscienceNot ratedAdvancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.
Showing the next 20 closest matches. See the rest on the ALP Bio profile.
Sponsored rows are paid and labelled. Advertise on this page
